Cargando…

Pseudomonas aeruginosa Bacteremia in Children Over Ten Consecutive Years: Analysis of Clinical Characteristics, Risk Factors of Multi-drug Resistance and Clinical Outcomes

This study aimed to evaluate the clinical profiles, antibiotic susceptibility, risk factors of multi-drug resistance (MDR) and outcomes of P. aeruginosa bacteremia in children by retrospective methods at a tertiary teaching children's hospital in Seoul, Korea during 2000-2009. A total of 62 epi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Mi Ae, Lee, Jina, Choi, Eun Hwa, Lee, Hoan Jong
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082111/ https://www.ncbi.nlm.nih.gov/pubmed/21532850 http://dx.doi.org/10.3346/jkms.2011.26.5.612

Ejemplares similares

Clinical Predictors of Pseudomonas aeruginosa Bacteremia in Emergency Department
por: Choi, Yongsoon, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

Pseudomonas aeruginosa bacteremia among liver transplant recipients
por: Liu, Taohua, et al.
Publicado: (2018)

Clinical characteristics and outcomes of Pseudomonas aeruginosa bacteremia in febrile neutropenic children and adolescents with the impact of antibiotic resistance: a retrospective study
por: Kim, Hyo Sup, et al.
Publicado: (2017)

Ceftolozane/Tazobactam Dosing Requirements Against Pseudomonas aeruginosa Bacteremia
por: Ruiz, Jesus, et al.
Publicado: (2020)

Duration of Treatment for Pseudomonas aeruginosa Bacteremia: a Retrospective Study
por: Babich, Tanya, et al.
Publicado: (2022)

Trends in Pseudomonas aeruginosa (P. aeruginosa) Bacteremia during the COVID-19 Pandemic: A Systematic Review
por: Ng, Qin Xiang, et al.
Publicado: (2023)

Ten Consecutive Laparotomies
por: Hardon, Virgil O.
Publicado: (1889)

P205: An outbreak of polyclonal pseudomonas aeruginosa bacteremia in hemodialysis patients
por: Ciobotaro, P, et al.
Publicado: (2013)

The Clinical Characteristics, Carbapenem Resistance, and Outcome of Acinetobacter Bacteremia According to Genospecies
por: Park, Kyung-Hwa, et al.
Publicado: (2013)

Successful Treatment of Multi-Drug Resistant Pseudomonas aeruginosa Bacteremia with the Recommended Renally Adjusted Ceftolozane/Tazobactam Regimen
por: Patel, Ursula C., et al.
Publicado: (2016)

Prognostic role of time to positivity of blood culture in children with Pseudomonas aeruginosa bacteremia
por: Xu, Huiting, et al.
Publicado: (2020)

Antimicrobial Susceptibility Trends and Risk Factors for Antimicrobial Resistance in Pseudomonas aeruginosa Bacteremia: 12-Year Experience in a Tertiary Hospital in Korea
por: Kang, Jin Suk, et al.
Publicado: (2021)

Outbreak of Pseudomonas aeruginosa Bacteremia Infections among Stem-Cell Transplant Patients Related to Change in Prophylaxis
por: VerLee, Kerrie, et al.
Publicado: (2021)

Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study
por: Lee, Chan Mi, et al.
Publicado: (2022)

Association of biofilm formation with multi drug resistance in clinical isolates of Pseudomonas aeruginosa
por: Abdulhaq, Nazia, et al.
Publicado: (2020)

Complete Genome Sequences of Two Pseudomonas aeruginosa Strains Isolated from Children with Bacteremia
por: Espinosa-Camacho, Luis F., et al.
Publicado: (2017)

Carbapenem-resistant and cephalosporin-susceptible Pseudomonas aeruginosa: a notable phenotype in patients with bacteremia
por: Li, Shuang, et al.
Publicado: (2018)

Pseudomonas aeruginosa bacteremia mortality and resistance trends in the Veterans’ Health Administration (VHA) system
por: Hojat, Leila, et al.
Publicado: (2022)

In host evolution of beta lactam resistance during active treatment for Pseudomonas aeruginosa bacteremia
por: Spottiswoode, Natasha, et al.
Publicado: (2023)

185. Pseudomonas aeruginosa (PA) Bacteremia and Patient Outcome during COVID-19 Pandemic
por: Vivekanandan, Renuga, et al.
Publicado: (2023)

Changes in Serotype Distribution and Antibiotic Resistance of Nasopharyngeal Isolates of Streptococcus pneumoniae from Children in Korea, after Optional Use of the 7-Valent Conjugate Vaccine
por: Cho, Eun Young, et al.
Publicado: (2012)

395 Impact of vancomycin pharmacokinetic/pharmacodynamic data on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children
por: Yoo, Reenar, et al.
Publicado: (2014)

Molecular epidemiology of Pseudomonas aeruginosa clinical isolates
por: Berber, Ismet, et al.
Publicado: (2016)

Nosocomial Pseudomonas putida Bacteremia: High Rates of Carbapenem Resistance and Mortality
por: Kim, Seong Eun, et al.
Publicado: (2012)

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies
por: Zhang, Yu, et al.
Publicado: (2016)

Pseudomonas aeruginosa bacteremia secondary to acute right leg cellulitis: case of community-acquired infection
por: Wahab, Asrul Abdul, et al.
Publicado: (2013)

Breakthrough Bacteremia with Meropenem-resistant Pseudomonas aeruginosa in Hematologic Malignancy Patients Receiving Levofloxacin Prophylaxis
por: Hakki, Morgan, et al.
Publicado: (2017)

Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms
por: Dantas, Raquel Cristina Cavalcanti, et al.
Publicado: (2017)

Septic shock secondary to an acute necrotizing community-acquired pneumonia with bacteremia due to Pseudomonas aeruginosa
por: Riviere, P., et al.
Publicado: (2019)

Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality
por: Zhang, Yulin, et al.
Publicado: (2020)

A rare case of Pseudomonas aeruginosa bacteremia in a newborn with 58 perforations in the small intestine
por: Xu, Yuanyuan, et al.
Publicado: (2021)

Follow-up blood cultures in Pseudomonas aeruginosa bacteremia: A potential target for diagnostic stewardship
por: Green, Alexis L., et al.
Publicado: (2021)

Prevalence and Susceptibility Pattern of Multi Drug Resistant Clinical Isolates of Pseudomonas aeruginosa in Karachi
por: Khan, Fouzia, et al.
Publicado: (2014)

Endophthalmitis Caused by Pseudomonas aeruginosa: Clinical Characteristics, Outcomes, and Antibiotics Sensitivities
por: Lin, Jiaqi, et al.
Publicado: (2022)

Clinical Characteristics of Actinomyces viscosus Bacteremia
por: Hsiao, Yi-Chun, et al.
Publicado: (2021)

Epidemiology and Burden of Influenza in Children 0–14 Years Over Ten Consecutive Seasons in Italy
por: Barbieri, Elisa, et al.
Publicado: (2023)

Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients
por: Kim, Dae Il, et al.
Publicado: (2010)

Impact of Definitive Therapy with Beta-Lactam Monotherapy or Combination with an Aminoglycoside or a Quinolone for Pseudomonas aeruginosa Bacteremia
por: Bliziotis, Ioannis A., et al.
Publicado: (2011)

Risk factors for mortality in patients with Pseudomonas aeruginosa bacteremia; retrospective study of impact of combination antimicrobial therapy
por: Kim, Youn Jeong, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_352qrrjbt5c88i9k6f4igtuigr